ISMP Raises Safety Concerns for 2 Novel Agents

By Nikki Kean

The postmarketing safety record of two recently approved drugs with novel mechanisms of action has raised concerns, leading investigators to examine how these agents got approved in the first place, according to a Quarterwatch report by the Institute for Safe Medication Practices (ISMP).